3
Announcements
Trials
Browse
Landscape
Status
Temporarily not available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
balstilimab
2
zipalertinib
1
telisotuzumab vedotin
1
nirogacestat
1
mirdametinib
1
mifamurtide
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
telisotuzumab vedotin
×
30 days
×
Clear all
NCT04830202
2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available